Gastrointestinal illnesses are a major cause of disease worldwide. The growth in incidence of Inflammatory Bowel Diseases (IBD) along with the continued effort to eradicate the causative agent of stomach cancer has led to the need for novel and non-invasive diagnostic testing. DiaSorin Stool Diagnostic products offer reliable diagnostic results.
Coming Soon ... Pending FDA Clearance
The LIAISON® Meridian H. pylori SA assay is a chemiluminescent immunoassay (CUA) intended for the qualitative determination of Helicobacter pylori (H. pylori) antigen in human stool. The test is an aid in the diagnosis of patients suspected of H. pylori infection and to measure post therapy response from patients who have discontinued therapy for at least 4 weeks.
Helicobacter pylori is a gram-negative, helix-shaped, bacterium found in the human stomach. It is the causative agent of chronic gastritis or inflammation of the stomach lining, duodenal and stomach ulcers, and is associated with an increased risk of stomach cancer. Unlike a majority of bacterial species, H. pylori is capable of colonizing the harsh acidic environment of the stomach. Once colonization of the stomach is established, H. pylori will likely persist indefinitely unless antimicrobial intervention is prescribed. Several methods are used to diagnose H. pylori infection including gastric biopsy, urea breath test (UBT), and stool testing.